Patents by Inventor Gregor Sagner
Gregor Sagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150315634Abstract: The present invention refers to a method and a kit for performing temperature calibration in high resolution melting PCR experiments. The present invention further refers to a method for optimal calibration allowing read-out of identical or similar melting temperatures for target and calibrator. The present invention further refers to an apparatus for performing the method and a computer program for executing the method.Type: ApplicationFiled: July 6, 2015Publication date: November 5, 2015Inventors: Astrid Reiser, Gregor Sagner
-
Patent number: 8906306Abstract: The present invention provides a fluid transfer control method, the method based on measurements of intensities of dyes within the fluid to be transferred. In more detail, the present invention makes use of control dyes and quencher molecules for the fluid transfer controls.Type: GrantFiled: March 29, 2010Date of Patent: December 9, 2014Assignee: Roche Molecular Systems, Inc.Inventors: Gregor Sagner, Martin Horat
-
Patent number: 8744777Abstract: The present invention concerns a method for the quantification of a target nucleic acid in a sample comprising the following steps: (i) determination of the amplification efficiency of the target nucleic acid under defined amplification conditions, (ii) amplification of the target nucleic acid contained in the sample under the same defined reaction conditions, (iii) measuring the amplification in real-time, (iv) quantification of the original amount of target nucleic acid in the sample by correction of the original amount derived from step (iii) with the aid of the determined amplification efficiency. The efficiency correction of PCR reactions according to the invention for the quantification of nucleic acids can be used for absolute quantification with the aid of an external or internal standard as well as for relative quantification compared to the expression of housekeeping genes.Type: GrantFiled: June 17, 2011Date of Patent: June 3, 2014Assignee: Roche Molecular Systems, Inc.Inventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong
-
Publication number: 20120270222Abstract: The present invention concerns a method for the quantification of a target nucleic acid in a sample comprising the following steps: (i) determination of the amplification efficiency of the target nucleic acid under defined amplification conditions, (ii) amplification of the target nucleic acid contained in the sample under the same defined reaction conditions, (iii) measuring the amplification in real-time, (iv) quantification of the original amount of target nucleic acid in the sample by correction of the original amount derived from step (iii) with the aid of the determined amplification efficiency. The efficiency correction of PCR reactions according to the invention for the quantification of nucleic acids can be used for absolute quantification with the aid of an external or internal standard as well as for relative quantification compared to the expression of housekeeping genes.Type: ApplicationFiled: June 17, 2011Publication date: October 25, 2012Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: GREGOR SAGNER, KARIM TABITI, MARTIN GUTEKUNST, RICHIE SOONG
-
Publication number: 20120070840Abstract: An analysis method for quantitative PCR experiments including multiple genes of interest, multiple samples and multiple conditions is provided. For calculating the relative expression status of multiple target genes from multiple samples under multiple different conditions, a calculation method based on up to three different parameters is performed. In addition to normalization against one or multiple reference gene(s) and normalization against a reference sample (calibrator), a third normalization step against a base value is performed in a target-, sample- and condition-specific manner.Type: ApplicationFiled: September 2, 2011Publication date: March 22, 2012Inventors: Ingrid Bechler, Gregor Sagner
-
Patent number: 8137616Abstract: The invention is directed to a system for performing multi-color real time PCT, comprising a flexible real time PCT instrument and a specific composition or reaction mixture for performing multiplex PCR: In particular, the present invention is directed to a composition or reaction mixture which comprises at least 3, preferably 4-5 and most preferably exactly 4 pairs of FRET hybridization probes. Each pair of said hybridization probes consists of a FRET donor probe carrying a FRET donor moiety and a FRET acceptor probe carrying a FRET acceptor moiety having an emission maximum between 550 and 710 nm.Type: GrantFiled: April 1, 2004Date of Patent: March 20, 2012Assignee: Roche Molecular Systems, Inc.Inventors: Gregor Sagner, Ingrid Bechler, Jochen Bolte, Dieter Heindl, Hans-Peter Josel, Martin Gutekunst, Rudolf Sebl, Christoph Mueller
-
Patent number: 8024132Abstract: The present invention concerns a method for the quantification of a target nucleic acid in a sample comprising the following steps: (i) determination of the amplification efficiency of the target nucleic acid under defined amplification conditions, (ii) amplification of the target nucleic acid contained in the sample under the same defined reaction conditions, (iii) measuring the amplification in real-time, (iv) quantification of the original amount of target nucleic acid in the sample by correction of the original amount derived from step (iii) with the aid of the determined amplification efficiency. The efficiency correction of PCR reactions according to the invention for the quantification of nucleic acids can be used for absolute quantification with the aid of an external or internal standard as well as for relative quantification compared to the expression of housekeeping genes.Type: GrantFiled: August 27, 2009Date of Patent: September 20, 2011Assignee: Roche Molecular SystemsInventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong
-
Publication number: 20110151550Abstract: The invention is directed to a system for performing multi-color real time PCR, comprising a flexible real time PCR instrument and a specific composition or reaction mixture for performing multiplex PCR: In particular, the present invention is directed to a composition or reaction mixture which comprises at least 3, preferably 4-5 and most preferably exactly 4 pairs of FRET hybridization probes. Each pair of said hybridization probes consists of a FRET donor probe carrying a FRET donor moiety and a FRET acceptor probe carrying a FRET acceptor moiety having an emission maximum between 550 and 710 nm.Type: ApplicationFiled: February 8, 2011Publication date: June 23, 2011Applicant: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Gregor Sagner, Ingrid Bechler, Jochen Bolte, Dieter Heindl, Hans-Peter Josel, Martin Gutekunst, Rudolf Sebl, Christoph Mueller
-
Publication number: 20110086337Abstract: The present invention provides a fluid transfer control method, the method based on measurements of intensities of dyes within the fluid to be transferred. In more detail, the present invention makes use of control dyes and quencher molecules for the fluid transfer controls.Type: ApplicationFiled: March 29, 2010Publication date: April 14, 2011Inventors: Gregor Sagner, Martin Horat
-
Publication number: 20100021923Abstract: The present invention concerns a method for the quantification of a target nucleic acid in a sample comprising the following steps: (i) determination of the amplification efficiency of the target nucleic acid under defined amplification conditions, (ii) amplification of the target nucleic acid contained in the sample under the same defined reaction conditions, (iii) measuring the amplification in real-time, (iv) quantification of the original amount of target nucleic acid in the sample by correction of the original amount derived from step (iii) with the aid of the determined amplification efficiency. The efficiency correction of PCR reactions according to the invention for the quantification of nucleic acids can be used for absolute quantification with the aid of an external or internal standard as well as for relative quantification compared to the expression of housekeeping genes.Type: ApplicationFiled: August 27, 2009Publication date: January 28, 2010Applicant: Roche Molecular Systems, Inc.Inventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong
-
Patent number: 7378241Abstract: The present invention concerns a method for determining the efficiency of the amplification of a target nucleic acid comprising the following steps: (i) preparation of a dilution series of the target nucleic acid, (ii) amplifying the target nucleic acid under defined reaction conditions, the amplification being measured in real-time (iii) setting a defined signal threshold value, (iv) determining the cycle number at which the signal threshold value is exceeded for various dilutions, (v) determining the amplification efficiency as a function of the amount of original target nucleic acid. The present invention also concerns a method for the quantification of a target nucleic acid in a sample in which the efficiency of the amplification reaction is determined in this manner and is taken into account in the quantification.Type: GrantFiled: March 25, 2004Date of Patent: May 27, 2008Assignee: Roche Diagnostics Operations, Inc.Inventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong
-
Publication number: 20070184453Abstract: The present invention is directed to hybridization probes hybridizing adjacently to another at a target nucleic acid sequence, wherein one member of said hybridization probes comprises (i) a nucleotide sequence entity which is substantially complementary to the sequence of the target nucleic acid, (ii) a fluorescent entity being either a FRET donor entity or a FRET acceptor entity, and (iii) a spacer entity connecting the nucleotide sequence entity and the fluorescent entity.Type: ApplicationFiled: October 1, 2003Publication date: August 9, 2007Applicant: ROCHE MOLECULAR SYSTEMS, INCInventors: Gregor Sagner, Dieter Heindl, Ingrid Bechler, Christina Krause
-
Publication number: 20060269922Abstract: The invention is directed to a system for performing multi-color real time PCT, comprising a flexible real time PCT instrument and a specific composition or reaction mixture for performing multiplex PCR: In particular, the present invention is directed to a composition or reaction mixtuer which comprises at least 3, preferably 4-5 and most preferably exactly 4 pairs of FRET hybridization probes. Each pair of said hybridization probes consists of a FRET donor probe carrying a FRET donor moiety and a FRET acceptor probe carrying a FRET acceptor moiety having an emission maximum between 550 and 710 nm.Type: ApplicationFiled: April 1, 2004Publication date: November 30, 2006Inventors: Gregor Sagner, Ingrid Bechler, Jochen Bolte, Dieter Heindl, Hans-Peter Josel, Martin Gutekunst, Rudolf Sebl, Christoph Mueller
-
Patent number: 7125691Abstract: The present invention concerns a method for determining the efficiency of the amplification of a target nucleic acid comprising the following steps: (i) preparation of a dilution series of the target nucleic acid, (ii) amplifying the target nucleic acid under defined reaction conditions, the amplification being measured in real-time (iii) setting a defined signal threshold value, (iv) determining the cycle number at which the signal threshold value is exceeded for various dilutions, (v) determining the amplification efficiency as a function of the amount of original target nucleic acid. The present invention also concerns a method for the quantification of a target nucleic acid in a sample in which the efficiency of the amplification reaction is determined in this manner and is taken into account in the quantification.Type: GrantFiled: March 30, 2001Date of Patent: October 24, 2006Assignee: Roche Molecular Systems, Inc.Inventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong
-
Publication number: 20060099596Abstract: The present invention is directed to a method for identification of a pathogenic organism from a predetermined group of pathogens, comprising (i) isolating a clinical sample containing at least partially purified nucleic acid, (ii) subjecting at least a first aliquot of said clinical specimen to at least one amplification and detection reaction in one reaction vessel comprising (iia) an amplification step using at least a first set of amplification primers capable of amplifying a preselected nucleic acid sequence region from several or all members of said predetermined group of pathogens, (iib) a detection step using at least 2, 3 or multiple hybridization reagents, said reagents together being capable of specifically detecting a pre-selected nucleic acid sequence region from all members of said group of pathogens, said detection step (iib) comprising steps monitoring hybridization of each of said hybridization reagents at a pre-selected temperature, said hybridization being indicative for at least the genusType: ApplicationFiled: December 2, 2003Publication date: May 11, 2006Applicant: Roche Molecular Systems, Inc.Inventors: Gerd Haberhausen, Thomas Emrich, Gregor Sagner, Martin Moczko, Gudrun Schmitz-Agheguian
-
Publication number: 20060051796Abstract: The present invention is directed to a method and a kit for amplifying and detecting a target nucleic acid, wherein the composition containing reagents to perform and monitor nucleic acid amplification in real time comprises at least a first hybridization probe labeled with a first fluorescent entity and a pyrophosphatase.Type: ApplicationFiled: August 25, 2005Publication date: March 9, 2006Inventors: Inga Boell, Anja Degen, Dieter Heindl, Gregor Sagner
-
Publication number: 20050176014Abstract: The invention is directed to a pair of FRET hybridization probes consisting of a first oligonucleotide carrying a FRET donor entity and a second oligonucleotide carrying a FRET acceptor entity, wherein said first oligonucleotide carrying the donor fluorescent entity is carrying at least one second entity, said second entity being a compound which is capable of quenching fluorescence emission of said donor fluorescent entity. In addition, the invention is directed to methods of using the same.Type: ApplicationFiled: July 16, 2003Publication date: August 11, 2005Applicant: ROCHE MOLECULAR SYSTEMS, INCInventors: Dieter Heindl, Hans-Peter Josel, Gregor Sagner, Jutta Mayr
-
Patent number: 6875850Abstract: The present invention concerns a labelling reagent in which the label is bound via an amide bond and a linker to a residue of the molecule which is essentially characterized in that the N atom of the amide bond and the label are linked together directly by a covalent bond. In particular these are phosphoramidites or reactive supports suitable for nucleic acid synthesis. The invention also concerns processes for the production of such supports from suitable precursors.Type: GrantFiled: August 30, 2001Date of Patent: April 5, 2005Assignee: Roche Diagnostics Operations, Inc.Inventors: Dieter Heindl, Gregor Sagner, Heribert Maerz, Herbert Von Der Eltz
-
Publication number: 20050042618Abstract: Compositions, reaction mixtures, and kits, as well as methods for their use, comprising a pair of FRET hybridization probes hybridizing adjacently to a target nucleic acid sequence, each hybridization probe comprising (i) a nucleotide sequence entity which is substantially complementary to the sequence of the target nucleic acid, (ii) a fluorescent entity, being either a FRET donor entity or a FRET acceptor entity, and (iii) a spacer entity connecting the nucleotide sequence entity and the fluorescent entity. The intensity of fluorescence emission from the FRET donor entity and from the FRET acceptor entity is not substantially affected by quenching activity of nucleotide residues present in the sequence of the target nucleic acid or in the nucleotide sequence entities of the hybridization probes.Type: ApplicationFiled: August 6, 2003Publication date: February 24, 2005Applicant: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Dieter Heindl, Hans-Peter Josel, Gregor Sagner, Ingrid Bechler
-
Publication number: 20050009048Abstract: The present invention concerns a method for determining the efficiency of the amplification of a target nucleic acid comprising the following steps: (i) preparation of a dilution series of the target nucleic acid, (ii) amplifying the target nucleic acid under defined reaction conditions, the amplification being measured in real-time (iii) setting a defined signal threshold value, (iv) determining the cycle number at which the signal threshold value is exceeded for various dilutions, (v) determining the amplification efficiency as a function of the amount of original target nucleic acid. The present invention also concerns a method for the quantification of a target nucleic acid in a sample in which the efficiency of the amplification reaction is determined in this manner and is taken into account in the quantification.Type: ApplicationFiled: March 25, 2004Publication date: January 13, 2005Inventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong